Stanford Virtual Biotech

Stanford’s 37,000 AI Agents Design Lung Cancer ADC Validated by Merck

Stanford’s 37,000-agent Virtual Biotech designed a lung cancer therapy later validated by Merck and found signals tied to 50% higher market success rates.